ELII: Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/13 → 5/31/19

Funding

  • National Institute of Allergy and Infectious Diseases: $3,512,751.00